| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/21/2004 | EP1381623A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/21/2004 | EP1381440A2 Electronic detection of interaction and detection of interaction based on the interruption of flow |
| 01/21/2004 | EP1381383A2 Methods of detecting multiple dna binding protein and dna interactions in a sample, and devices, systems and kits for practicing the same |
| 01/21/2004 | EP1381369A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence |
| 01/21/2004 | EP1381349A1 Tyrosinase assay |
| 01/21/2004 | EP1381272A2 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors |
| 01/21/2004 | EP1191942B1 Use of antileukoprotease for the treatment of endometriosis |
| 01/21/2004 | EP0863982B1 Synthetic hpv11 virus-like particles |
| 01/21/2004 | EP0842276B1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv) |
| 01/21/2004 | CN2600812Y Disposable reaction cup for automatic biochemical instrument |
| 01/21/2004 | CN1469932A Non-invasion prenatal monitoring |
| 01/21/2004 | CN1469926A Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/21/2004 | CN1469883A Peptide selection method |
| 01/21/2004 | CN1469775A Particulate support for separation/purification or extraction and process for producing the same |
| 01/21/2004 | CN1469758A Detection of the presence of a microbe or related substance at a location |
| 01/21/2004 | CN1469739A Method for modulating bladder function |
| 01/21/2004 | CN1469134A Microbe tracing method for oil deposit well |
| 01/21/2004 | CN1469123A Microflow control chip for protein analysis and its application in protein analysis |
| 01/21/2004 | CN1469111A Method and equipment for fast distinguishing particles utilizing with scattered light histogram |
| 01/21/2004 | CN1468966A Method of detecting tumor gene with boichip |
| 01/21/2004 | CN1468965A Gene detection reagent kit for SARS virus and its detection method |
| 01/21/2004 | CN1468955A New type of coronavirus |
| 01/21/2004 | CN1135390C Method of electrochemical detection for analyte in sample |
| 01/21/2004 | CN1135388C Multilayer reagent test strip and method for making test with the same |
| 01/20/2004 | USRE38392 Comparing amplified expressed rna sequences of transfected cells with amplified expressed rna sequences of the metastasis and identifying the sequence expressed at a higher level in metastasis compared to the rna sequences of tranfected cells |
| 01/20/2004 | US6681186 Data processing, computers |
| 01/20/2004 | US6680427 Chimeric gene encoding mlo-like polypeptide in sense or antisense orientation; gene expression, engineering; fungal diseases in plants |
| 01/20/2004 | US6680378 Restriction endonuclease digest; gel electrophoresis; comparing staining intensity |
| 01/20/2004 | US6680377 Nucleic acid-based detection |
| 01/20/2004 | US6680375 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
| 01/20/2004 | US6680373 Polypeptide for use in the human diagnostics and therapeutics |
| 01/20/2004 | US6680370 Diagnosing defective mesangial cells; glomerulosclerosis, nephritis, and diabetic nephropathy treatment |
| 01/20/2004 | US6680369 Nucleotide sequences coding protein for use in treatment cytoskeletal defects |
| 01/20/2004 | US6680368 Protein encoded by dna |
| 01/20/2004 | US6680342 Monitoring the proliferation of cultured prostate cancer cells; obtain cells, incubate with quercetin, monitor adjustment in gene expression, decrease in androgen receptor gene expression indicate cell proliferation inhibitor |
| 01/20/2004 | US6680203 Fourier transform mass spectrometry of complex biological samples |
| 01/20/2004 | US6680197 Breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, and t cells that are specific for cells expressing such polypeptides. |
| 01/20/2004 | US6680188 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/20/2004 | US6680178 Solid support containing a fluorogenic-leaving group, such as 7-amino-4-carbamoylmethyl-coumarin (acc) linked to an amino acid or peptide; cleavage of the peptide by a protease results in liberation of the leaving group for quantitative analysis |
| 01/20/2004 | US6680177 Coagulation cascade reaction and monitoring coagulation times or kinetics, wherein the coagulation reagent is a dry format reagent comprising magnetic particles and a factor xa activator |
| 01/20/2004 | US6680175 Diagnosing cancer in humans; obtain biopsy of human tissue, detect and measure signal from bound polypeptide marker, evaluate humans for cancer |
| 01/20/2004 | US6680171 Drug screening, genetic engineering |
| 01/20/2004 | US6680170 Polynucleotides encoding STE20-related protein kinases and methods of use |
| 01/20/2004 | US6680167 Molecules of the card-related protein family and uses thereof |
| 01/20/2004 | US6680025 Device and method for photoactivation |
| 01/20/2004 | CA2264343C Method and apparatus for data management authentication in a clinical analyzer |
| 01/18/2004 | CA2432925A1 Enzymatic assay of hiv protease inhibitors |
| 01/16/2004 | CA2393726A1 Quantitative proteomics via isotopically differentiated derivatization |
| 01/15/2004 | WO2004006161A1 Movement of multi-enzymatic nanoassemblies on recognition landscapes |
| 01/15/2004 | WO2004005927A1 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 01/15/2004 | WO2004005922A2 Monitoring of cells |
| 01/15/2004 | WO2004005920A2 Method for enriching and tracking pathologic modified prions-proteins (prpsc) |
| 01/15/2004 | WO2004005918A2 Characterization of biochips containing self-assembled monolayers with maldi-tof-ms |
| 01/15/2004 | WO2004005908A1 Biosensor, biosensor chip, and biosensor device |
| 01/15/2004 | WO2004005901A1 Detection of molecular identification by electrochemiluminescence on conductive polymer |
| 01/15/2004 | WO2004005889A2 Detection of drug-resistant human immunodeficiency virus |
| 01/15/2004 | WO2004005888A2 Method for metal analysis and speciation and biosensor for effecting the method |
| 01/15/2004 | WO2004005887A2 Methods and compositions for the detection of pregnancy in ruminants |
| 01/15/2004 | WO2004005886A2 Kits and methods for assessing cardiovascular health |
| 01/15/2004 | WO2004005881A2 Methods for identification of compounds modulating insulin resistance |
| 01/15/2004 | WO2004005871A1 A method of studying living cells |
| 01/15/2004 | WO2004005555A1 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom |
| 01/15/2004 | WO2004005554A2 Antisense modulation of livin expression |
| 01/15/2004 | WO2004005549A1 Method of estimating effect of interferon |
| 01/15/2004 | WO2004005548A2 A method for discovery of human genes associated with viral hepatitis infection |
| 01/15/2004 | WO2004005547A2 Method for identifying hypersensitive site consensus sequences |
| 01/15/2004 | WO2004005546A1 Screening for anti-ovulatory compounds |
| 01/15/2004 | WO2004005545A1 Method and test kit for quantitative determination of polynucleotides in a mixture |
| 01/15/2004 | WO2004005544A2 Marker genes for determining renal toxicity |
| 01/15/2004 | WO2004005543A1 Methods and nucleic acids for the analysis of methylation patterns within the dd3 gene |
| 01/15/2004 | WO2004005542A2 Method for identifying infection-specific regulated genes of the skin |
| 01/15/2004 | WO2004005541A1 Diagnostic tests for the detection of peripheral neuropathy |
| 01/15/2004 | WO2004005540A2 Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases |
| 01/15/2004 | WO2004005539A1 Diagnosis of sepsis using mitochondrial nucleic acid assays |
| 01/15/2004 | WO2004005538A1 Method of screening anticancer agent |
| 01/15/2004 | WO2004005537A1 Detection of microorganisms with holographic sensor |
| 01/15/2004 | WO2004005536A1 Nephrotoxicity marker fumarylacetoacetase |
| 01/15/2004 | WO2004005535A2 Pathogenicity proteins which can be used as targets for developing means for preventing and controlling bacterial infections |
| 01/15/2004 | WO2004005534A2 Screening for alzheimer's disease |
| 01/15/2004 | WO2004005529A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/15/2004 | WO2004005499A1 Glucose dehydrogenase |
| 01/15/2004 | WO2004005484A2 Snrks as modifiers of chk and branching morphogenesis and methods of use |
| 01/15/2004 | WO2004005481A2 Methods for identifying modulators of mda-7 mediated apoptosis |
| 01/15/2004 | WO2004005480A2 Plastid genetic engineering via somatic embryogenesis |
| 01/15/2004 | WO2004005479A2 A high resolution typing system for pathogenic borrelia |
| 01/15/2004 | WO2004005476A2 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | WO2004005468A2 Axs gene and protein and methods related thereto |
| 01/15/2004 | WO2004005466A2 Methods and compositions for diagnosing hepatocellular carcinoma |
| 01/15/2004 | WO2004005465A2 Compositions and methods for the detection of human t cell receptor variable family gene expression |
| 01/15/2004 | WO2004005462A2 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 01/15/2004 | WO2004005458A2 Functional sites |
| 01/15/2004 | WO2004005457A2 Tfc/ beta-catenin regulated genes for treating cancer |
| 01/15/2004 | WO2004005451A2 Method for detecting the von willebrand factor-cleaving protease activity of adamts-13 |
| 01/15/2004 | WO2004005322A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | WO2004005315A2 Pin1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design |
| 01/15/2004 | WO2004004785A1 Mchks as modifiers of the chk1 pathway and methods of use |
| 01/15/2004 | WO2004004771A1 Immunopotentiating compositions |
| 01/15/2004 | WO2004004752A1 Caspase 9 activation and uses therefor |
| 01/15/2004 | WO2004004666A2 Modulators of leukocyte activation, hck compositions and methods of use |
| 01/15/2004 | WO2004004652A2 Mitotic kinesin binding site |